{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:46:59Z","timestamp":1789984019664,"version":"4.0.1"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Primary coenzyme Q10 (CoQ10) deficiency is an autosomal recessive genetic disease caused by mitochondrial dysfunction. Variants in Coenzyme Q8B (<jats:italic>COQ8B<\/jats:italic>) can cause primary CoQ10 deficiency. <jats:italic>COQ8B<\/jats:italic>-related glomerulopathy is a recently recognized glomerular disease that most often presents as steroid-resistant nephrotic syndrome (SRNS) in childhood. The disease often progresses to kidney failure and the renal histopathology is most commonly focal segmental glomerulosclerosis (FSGS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Four SRNS cases (2 females and 2 males) from 2 unrelated families who were followed clinically for nearly 3 years. Clinical exome testing and analyses were performed by MyGenostics Laboratory in China to evaluate unexplained proteinuria given the strong family history of glomerular disease and histologic evidence of SRNS. Pathogenic variants were identified in <jats:italic>COQ8B<\/jats:italic> in the exome studies and confirmed by direct sequencing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Clinical exome sequencing revealed biallelic variants of the <jats:italic>COQ8B<\/jats:italic> gene in 2 families. In the Family 1, the oldest of three affected siblings died of renal failure at 11 years of age. Based on the results of genetic testing which identified a homozygous variant of <jats:italic>COQ8B<\/jats:italic>, the other two affected siblings with mild proteinuria and normal renal function were treated with CoQ10 oral supplementation at an early stage. Coenzyme Q10 treatment was effective in reducing proteinuria levels in both patients from Family 1 over the first 6 months and the two patients still have low-level proteinuria and normal renal function at nearly three years. In Family 2, clinical exome sequencing revealed a compoundheterozygous variants of <jats:italic>COQ8B<\/jats:italic> in a patient with biopsy- proven FSGS. His disease was unresponsive to prior treatment with glucocorticoids and cyclosporine. Oral CoQ10 was initiated based on his genetic diagnosis and was it was effective in reducing proteinuria over the first 5 months months of therapy. However after 1 year, his disease progressed tokidney failure. Kidney transplantation was performed at 5 years of age and his condition has been stable without rejection and no recurrence of disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p><jats:italic>COQ8B<\/jats:italic> gene variant-related glomerulopathy often presents as SRNS without obvious extrarenal manifestations. The histopathology is mainly FSGS and follows an autosomal recessive mode of inheritance. Some patients may benefit from early coenzyme Q10 supplementation. For patients whose disease progresses to kidney failure, kidney transplantation can be an effective treatment. For children with unexplained proteinuria and abnormal renal function, genetic testing should be performed early in the course of disease to guide therapy where possible and improve prognosis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2024.1378083","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T06:14:07Z","timestamp":1736835247000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical follow-up of 2 families with glomerulopathy caused by COQ8B gene variants and literature review"],"prefix":"10.3389","volume":"12","author":[{"given":"Lei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gentzon","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peitong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunzhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyuan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/ajmg.a.61909","article-title":"The role of novel COQ8B mutations in glomerulopathy and related kidney defects","volume":"185","author":"AbuMaziad","year":"2021","journal-title":"Am J Med Genet A"},{"key":"B2","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/humu.23376","article-title":"Mutations in COQ8B (ADCK4) found in patients with steroid-resistant nephrotic syndrome alter COQ8B function","volume":"39","author":"Vazquez Fonseca","year":"2018","journal-title":"Hum Mutat"},{"key":"B3","doi-asserted-by":"publisher","first-page":"885178","DOI":"10.3389\/fmed.2022.885178","article-title":"The clinical and genetic features in Chinese children with steroid-resistant or early-onset nephrotic syndrome: a multicenter cohort study","volume":"9","author":"Zhu","year":"2022","journal-title":"Front Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1681\/ASN.2014121240","article-title":"ADCK4 - associated glomerulopathy causes adolescence-onset FSGS","volume":"27","author":"Korkmaz","year":"2016","journal-title":"J Am Soc Nephrol JASN"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5179","DOI":"10.1172\/JCI69000","article-title":"ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption","volume":"123","author":"Ashraf","year":"2013","journal-title":"J Clin Invest"},{"key":"B6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2215\/CJN.04120417","article-title":"Whole exome sequencing of patients with steroid-resistant nephrotic syndrome","volume":"13","author":"Warejko","year":"2018","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s00467-017-3657-9","article-title":"Focal segmental glomerulosclerosis and medullary nephrocalcinosis in children with ADCK4 mutations","volume":"32","author":"Park","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00467-017-3590-y","article-title":"Spectrum of mutations in Chinese children with steroid-resistant nephrotic syndrome","volume":"32","author":"Wang","year":"2017","journal-title":"Pediatr Nephrol Berl Ger"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e1360","DOI":"10.1002\/mgg3.1360","article-title":"COQ8B nephropathy: early detection and optimal treatment","volume":"8","author":"Song","year":"2020","journal-title":"Mol Genet Genomic Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/s12882-020-02040-z","article-title":"A case report of adult-onset COQ8B nephropathy presenting focal segmental glomerulosclerosis with granular swollen podocytes","volume":"21","author":"Maeoka","year":"2020","journal-title":"BMC Nephrol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s12882-020-02038-7","article-title":"Early-onset COQ8B (ADCK4) glomerulopathy in a child with isolated proteinuria: a case report and literature review","volume":"21","author":"Zhai","year":"2020","journal-title":"BMC Nephrol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e8880","DOI":"10.1097\/MD.0000000000008880","article-title":"Coenzyme Q10 supplementation therapy for 2 children with proteinuria renal disease and ADCK4 mutation: case reports and literature review","volume":"96","author":"Feng","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"657","DOI":"10.24953\/turkjped.2019.05.003","article-title":"Long-term follow-up results of patients with adck4 mutations who have been diagnosed in the asymptomatic period: effects of early initiation of coq10 supplementation","volume":"61","author":"Atmaca","year":"2019","journal-title":"Turk J Pediatr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.kint.2022.04.029","article-title":"Oral coenzyme Q10 supplementation leads to better preservation of kidney function in steroid-resistant nephrotic syndrome due to primary coenzyme Q10 deficiency","volume":"102","author":"Drovandi","year":"2022","journal-title":"Kidney Int"},{"key":"B15","article-title":"Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency - PubMed","year":""},{"key":"B16","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.bbrc.2018.10.102","article-title":"A novel ADCK4 mutation in a Chinese family with ADCK4-associated glomerulopathy","volume":"506","author":"Yang","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ekir.2022.10.030","article-title":"A systematic review and meta-analysis of the rate and risk factors for post-transplant disease recurrence in children with steroid resistant nephrotic syndrome","volume":"8","author":"Morello","year":"2023","journal-title":"Kidney Int Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1030191","DOI":"10.3389\/fped.2022.1030191","article-title":"Clinical features and gene variation analysis of COQ8B nephropathy: report of seven cases","volume":"10","author":"Liang","year":"2022","journal-title":"Front Pediatr"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1378083\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T06:14:11Z","timestamp":1736835251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1378083\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":18,"alternative-id":["10.3389\/fped.2024.1378083"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1378083","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"article-number":"1378083"}}